58 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
14 Jun 24
Condensed Consolidated Financial Statements
4:30pm
-Current Liabilities
Other long-term liabilities
Total Non-Current Liabilities
Commitments and Contingent Liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY … , that the Company will be successful in obtaining the financing necessary for its long-term development. The Company’s ability to continue to operate in the long
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Jun 24
Report of Foreign Private Issuer
8:05am
and anti-inflammatory medication to reduce pain and swelling start losing their effectiveness. Currently, there are no effective long-term treatments
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and other liabilities (note 8)
Liability classified as held for sale (note 16)
Total Current Liabilities
Non-Current Liabilities
Other long-term Liabilities … term, revenues. There are no assurances, however, that the Company will be successful in obtaining the financing necessary for its long-term development
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
and long-term lease liabilities, as applicable.
Operating lease liabilities and their corresponding right-of-use assets are initially recorded based
6-K
EX-99.1
a9m05wxnp2 236y
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
nxw6l7 l114bordmvi
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
wikm7rdr
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
EX-99.1
nkpq7y2pd1 kcl2gybc
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
6lusmx7wex i6r1
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
st3f 5hr00
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.2
hrr05x3zcu7j5pyuly4
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
zl4lv sa19srqamt
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
dsssmsk vvd0
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
cqw3rzw44d4 9ydqel
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
us1zeb47yccem67v
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
bjy84h p9v
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
rgye0t
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
n6jb u6aix4684k2
12 Sep 22
Report of Foreign Private Issuer
8:02am